[CITATION][C] Long-term treatment of mild to moderate Alzheimer disease in a 77-year-old female patient.

P Gillette - The Journal of the American Board of Family …, 2002 - Am Board Family Med
Discussion This case illustrates the value of a proactive approach to diagnosing Alzheimer
disease and the importance of initiating treatment early in the disease course. This case also …

Donepezil Use for Advanced Alzheimer's Disease—A Case Study from a Long-term Care Facility

PN Tariot, L Jakimovich - Journal of the American Medical Directors …, 2003 - Elsevier
The following case describes a severely demented, elderly male patient who was placed in
a nursing home when he became unmanageable in an assisted-living facility. Upon …

[HTML][HTML] Disappointing Outcomes with Alzheimer's Medication

AD Walling - American Family Physician, 2005 - aafp.org
Alzheimer's disease is a large and increasing public health problem. Because the cognitive
deficits of the disease are thought to result from degeneration of cholinergic basal fore-brain …

The Efficacy of Donepezil in Alzheimer's Disease.

伊藤敬雄, 山寺博史 - Journal of Nippon Medical School, 2002 - jlc.jst.go.jp
Several studies have reported the efficacy of donepezil (a cholinesterase inhibitor) in
patients with Alzheimer's Disease, not only for memory disturbances but also for psychotic …

[HTML][HTML] Cholinesterase inhibitors for Alzheimer's disease

N Hitzeman - American Family Physician, 2006 - aafp.org
A 72-year-old woman is brought into the office by her daughter, who complains that her
mother has become increasingly forgetful over the past two years. On a Mini-Mental State …

Diagnosis and Treatment of Early Alzheimer's Disease

B Zepf - American Family Physician, 2004 - search.proquest.com
Alzheimer's disease accounts for the majority of dementia cases, but a substantial number of
persons may be affected by other dementias, including vascular dementia (10 to 20 percent …

A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study

H Arai, T Takahashi - The American Journal of Geriatric …, 2009 - Am Assoc Geria Psych
Alzheimer disease (AD) after the resumption of the deterioration process during
acetylcholinesterase inhibitor therapy. New drugs for AD, such as immunotherapy or …

Donepezil for Alzheimer's disease

N Sparano - Journal of Family Practice, 1998 - go.gale.com
Background Alzheimer's disease is characterized by memory and cognitive deficits
associated with losses of presynaptic cholinergic function in the brain. Agents that block …

Discontinuing donepezil or starting memantine for Alzheimer's disease

LS Schneider - New England Journal of Medicine, 2012 - Mass Medical Soc
Donepezil, the most frequently prescribed cholinesterase inhibitor for the treatment of
Alzheimer's disease, was marketed in 1997 on the basis of the results of 3-month and 6 …

Diagnosis and management of Alzheimer Disease

MP Daly - The Journal of the American Board of Family …, 1999 - Am Board Family Med
Background: Alzheimer disease afflicts millions of older Americans, with an estimated cost to
society approaching $100 million annually. Family physicians will care for an increasing …